LATIN AMERICA COMPANION DIAGNOSTICS MARKET 2022-2028

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA COMPANION DIAGNOSTICS MARKET 2022-2028

Market by Mechanism, Indicator, Consumer, Commodity, and Country Outlook | Forecast 2022-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton’s research report, the companion diagnostics market in Latin America is estimated to advance with a CAGR of 12.10% over the forecasted period 2022-2028.



Report scope can be customized per your requirements. Request For Customization 

The countries examined in the given region are:

•         Brazil

•         Mexico

•         Rest of Latin America

In Latin America, Brazil captures the largest share in the studied market. The region has witnessed robust growth in precision medicine technology, owing to various initiatives to promote R&D. In this regard, pharmaceutical companies, diagnostics firms, and service providers are collaborating to facilitate access to precision medicine technologies. Further, the improvement in public-private partnerships has resulted in easy access to hospitals in small cities. Such developments are facilitating the expansion of companion diagnostics technology across the region to a large extent.

The Ministry of Health formulated a campaign to advance Brazil’s companion diagnostics sector, enhancing access to high-quality molecular testing. This has resulted in various partnerships among government, regulatory agencies, pharmaceutical companies, and academic institutes to support CDx technology.

Furthermore, Brazil’s dominance over the market is expected to continue over the next few years, owing to the rising focus on precision medicine. For instance, the Brazilian initiatives on precision medicine offer a platform that permits sharing of genetic and clinical data. Thus, as mentioned above, these factors support the companion diagnostics market’s growth.

The rise in cancer cases globally is expected to boost the adoption of companion diagnostics devices. In this regard, these devices are used to develop accurate medicine for specific cancer cases. Besides this, the advanced drugs developed using companion diagnostics devices enable precise treatment and quick recovery. The studied market’s growth is examined in terms of indicator, consumer, commodity, and mechanism. The indicator section includes oncology, infectious diseases, neurology, and other indicators.

The leading companies in the market consist of Illumina Inc, Qiagen, Sysmex Corporation, Thermo Fisher Scientific, Agilent, and Roche Diagnostics.

Sysmex Corporation designs, manufactures, and markets diagnostics devices, reagents, and related software for immunochemistry, hematology, urinalysis, clinical chemistry, and hemostasis. The company offers systems for high-volume testing in labs and blood cell differentiation for hematology applications. Besides this, the company provides automated equipment systems. Sysmex serves numerous clients, including private hospitals, universities, research institutes, and public hospitals.

 

Key deliverables of the report:

·       Market CAGR during the forecasting years 2022-2028

·       Detailed data highlighting key insights, industry components, and market strategies

·     Comprehensive information and estimation of the companion diagnostics market revenue growth in Latin America and its influence on the parent market

·       In-depth study of forthcoming trends in consumer behavioral patterns

·       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

·    A wide-ranging study of factors that will challenge the LA companion diagnostics market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA COMPANION DIAGNOSTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE COMPANION DIAGNOSTICS MARKET

2.2. KEY INSIGHTS

2.2.1. COMMERCIAL SUCCESS OF PRECISION MEDICINE TREATMENT

2.2.2. ADOPTION OF PREDICTIVE BIOMARKERS

2.2.3. FUSION OF COMPUTER SCIENCE AND BIOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. COST

2.4.2. AVAILABILITY

2.4.3. SENSITIVITY & SPECIFICITY

2.4.4. EFFICACY

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1. ACQUISITIONS

2.9.2. PRODUCT LAUNCHES

2.9.3. CONTRACTS & AGREEMENTS

2.10. MARKET DRIVERS

2.10.1. INCREASE IN INCIDENCE OF MEDICATION REACTIONS

2.10.2. INCREASING PREVALENCE OF CANCER CASES AND FATALITIES

2.10.3. RISING PREVALENCE OF PRECISION MEDICINES

2.11. MARKET CHALLENGES

2.11.1. WEAK REIMBURSEMENT FRAMEWORK

2.11.2. COMMON CASES OF LEAKAGE IN ONCOLOGY COMPANION DIAGNOSTICS

2.12. MARKET OPPORTUNITY

2.12.1. ONGOING RESEARCH AND INVESTMENTS IN NEXT GENERATION GENE-SEQUENCING

3. LATIN AMERICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY MECHANISM

3.1. IN-SITU HYBRIDIZATION

3.2. POLYMERASE CHAIN REACTION

3.3. IMMUNOHISTOCHEMISTRY

3.4. NEXT GENERATION SEQUENCING

3.5. OTHER MECHANISMS

4. LATIN AMERICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY INDICATOR

4.1. ONCOLOGY

4.2. NEUROLOGY

4.3. INFECTIOUS DISEASES

4.4. OTHER INDICATORS

5. LATIN AMERICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY CONSUMER

5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

5.2. REFERENCE LABORATORIES

5.3. OTHER CONSUMERS

6. LATIN AMERICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY COMMODITY

6.1. ASSAY KITS AND REAGENTS

6.2. SOFTWARE AND SERVICES

7. LATIN AMERICA COMPANION DIAGNOSTICS MARKET - COUNTRY OUTLOOK

7.1. BRAZIL

7.2. MEXICO

7.3. REST OF LATIN AMERICA

8. COMPETITIVE LANDSCAPE

8.1. ABBOTT LABORATORIES

8.2. ALMAC GROUP

8.3. ARUP LABORATORIES

8.4. BIOCARTIS

8.5. BIOMERIEUX

8.6. DANAHER CORPORATION

8.7. GE HEALTHCARE

8.8. GENOMIC HEALTH

8.9. ILLUMINA INC

8.10. MYRIAD GENETICS

8.11. QIAGEN

8.12. ROCHE DIAGNOSTICS

8.13. SYSMEX CORPORATION

8.14. THERMO FISHER SCIENTIFIC

8.15. AGILENT

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: LIST OF ACQUISITIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF CONTRACTS & AGREEMENTS

TABLE 6: NUMBER OF CANCER PATIENTS IN 2020

TABLE 7: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)

TABLE 8: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)

TABLE 9: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)

TABLE 10: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)

TABLE 11: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: INDUSTRY COMPONENTS

FIGURE 3: FDA FRAMEWORK

FIGURE 4: CDX LEAKAGE POINTS

FIGURE 5: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2021 & 2028 (IN %)

FIGURE 6: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY IN-SITU HYBRIDIZATION, 2022-2028 (IN $ MILLION)

FIGURE 7: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY POLYMERASE CHAIN REACTION, 2022-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY IMMUNOHISTOCHEMISTRY, 2022-2028 (IN $ MILLION)

FIGURE 9: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY NEXT GENERATION SEQUENCING, 2022-2028 (IN $ MILLION)

FIGURE 10: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY OTHER MECHANISMS, 2022-2028 (IN $ MILLION)

FIGURE 11: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2021 & 2028 (IN %)

FIGURE 12: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY ONCOLOGY, 2022-2028 (IN $ MILLION)

FIGURE 13: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY NEUROLOGY, 2022-2028 (IN $ MILLION)

FIGURE 14: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY INFECTIOUS DISEASES, 2022-2028 (IN $ MILLION)

FIGURE 15: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY OTHER INDICATORS, 2022-2028 (IN $ MILLION)

FIGURE 16: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2021 & 2028 (IN %)

FIGURE 17: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 18: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY REFERENCE LABORATORIES, 2022-2028 (IN $ MILLION)

FIGURE 19: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY OTHER CONSUMERS, 2022-2028 (IN $ MILLION)

FIGURE 20: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2021 & 2028 (IN %)

FIGURE 21: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY ASSAY KITS AND REAGENTS, 2022-2028 (IN $ MILLION)

FIGURE 22: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, BY SOFTWARE AND SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 23: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 24: BRAZIL COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

FIGURE 25: MEXICO COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

FIGURE 26: REST OF LATIN AMERICA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying